Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-2094 (Electronic) Linking ISSN: 17422094 NLM ISO Abbreviation: J Neuroinflammation Subsets: MEDLINE
- بيانات النشر:
Original Publication: [London] : BioMed Central, c2004-
- الموضوع:
- نبذة مختصرة :
Background: Cerebrospinal fluid from amyotrophic lateral sclerosis patients (ALS-CSF) induces neurodegenerative changes in motor neurons and gliosis in sporadic ALS models. Search for identification of toxic factor(s) in CSF revealed an enhancement in the level and enzyme activity of chitotriosidase (CHIT-1). Here, we have investigated its upregulation in a large cohort of samples and more importantly its role in ALS pathogenesis in a rat model.
Methods: CHIT-1 level in CSF samples from ALS (n = 158), non-ALS (n = 12) and normal (n = 48) subjects were measured using ELISA. Enzyme activity was also assessed (ALS, n = 56; non-ALS, n = 10 and normal-CSF, n = 45). Recombinant CHIT-1 was intrathecally injected into Wistar rat neonates. Lumbar spinal cord sections were stained for Iba1, glial fibrillary acidic protein and choline acetyl transferase to identify microglia, astrocytes and motor neurons respectively after 48 h of injection. Levels of tumour necrosis factor-α and interleukin-6 were measured by ELISA.
Findings: CHIT-1 level in ALS-CSF samples was increased by 20-fold and it can distinguish ALS patients with a sensitivity of 87% and specificity of 83.3% at a cut off level of 1405.43 pg/ml. Enzyme activity of CHIT-1 was also 15-fold higher in ALS-CSF and has a sensitivity of 80.4% and specificity of 80% at cut off value of 0.1077989 μmol/μl/min. Combining CHIT-1 level and activity together gave a positive predictive value of 97.78% and negative predictive value of 100%. Administration of CHIT-1 increased microglial numbers and astrogliosis in the ventral horn with a concomitant increase in the levels of pro-inflammatory cytokines. Amoeboid-shaped microglial and astroglial cells were also present around the central canal. CHIT-1 administration also resulted in the reduction of motor neurons.
Conclusions: CHIT-1, an early diagnostic biomarker of sporadic ALS, activates glia priming them to attain a toxic phenotype resulting in neuroinflammation leading to motor neuronal death.
- References:
PLoS One. 2012;7(12):e52941. (PMID: 23300829)
Neurobiol Dis. 2011 Mar;41(3):695-705. (PMID: 21168498)
Clin Proteomics. 2013 Dec 02;10(1):19. (PMID: 24295388)
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9. (PMID: 11464847)
J Neurol Sci. 2010 Sep 15;296(1-2):47-54. (PMID: 20619856)
Restor Neurol Neurosci. 2003;21(3-4):109-21. (PMID: 14530574)
Amyotroph Lateral Scler. 2010;11(1-2):166-71. (PMID: 20184518)
J Cell Biol. 2009 Dec 14;187(6):761-72. (PMID: 19951898)
J Neurol Sci. 2015 Jan 15;348(1-2):245-50. (PMID: 25563799)
Mult Scler. 2011 May;17(5):521-31. (PMID: 21159721)
Mov Disord. 2010 Sep 15;25(12):1868-75. (PMID: 20669307)
Brain Res. 2002 Jun 14;940(1-2):102-4. (PMID: 12020881)
Structure. 1995 Sep 15;3(9):853-9. (PMID: 8535779)
J Neuroinflammation. 2017 Dec 16;14(1):251. (PMID: 29246232)
Mult Scler. 2006 Oct;12(5):551-7. (PMID: 17086899)
Am J Neurodegener Dis. 2012;1(3):305-15. (PMID: 23383400)
BMC Neurol. 2016 Sep 15;16:173. (PMID: 27634542)
Neurodegeneration. 1995 Dec;4(4):397-401. (PMID: 8846233)
Behav Brain Res. 2010 Jan 5;206(1):109-19. (PMID: 19747511)
NMR Biomed. 2017 Dec;30(12):. (PMID: 28926131)
J Neurol Sci. 2007 Mar 15;254(1-2):9-16. (PMID: 17254611)
J Allergy Clin Immunol. 2005 Sep;116(3):497-500. (PMID: 16159614)
Nat Biotechnol. 2011 Aug 10;29(9):824-8. (PMID: 21832997)
J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):239-247. (PMID: 29142138)
Ann Neurol. 2018 Feb;83(2):258-268. (PMID: 29331073)
Nat Neurosci. 2009 Mar;12(3):259-67. (PMID: 19234458)
J Alzheimers Dis. 2012;32(2):273-6. (PMID: 22785399)
Neuroimage Clin. 2015 Jan 19;7:409-14. (PMID: 25685708)
Neuromolecular Med. 2011 Jun;13(2):151-9. (PMID: 21567187)
Neurosci Lett. 2010 Mar 31;473(1):56-61. (PMID: 20170712)
PLoS One. 2017 Feb 7;12(2):e0171668. (PMID: 28170441)
J Neuroinflammation. 2010 Jan 28;7:8. (PMID: 20109233)
Acta Neurol Scand. 2010 May;121(5):309-14. (PMID: 19925532)
Brain Res. 2009 Mar 31;1263:122-33. (PMID: 19368830)
J Neural Transm (Vienna). 2014 Jan;121(1):49-58. (PMID: 23900732)
Am J Pathol. 1992 Mar;140(3):691-707. (PMID: 1347673)
Acta Neuropathol Commun. 2020 May 7;8(1):65. (PMID: 32381112)
Neuron. 2006 Oct 5;52(1):39-59. (PMID: 17015226)
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16021-6. (PMID: 17043238)
J Neurol Sci. 2001 Jun 15;187(1-2):27-34. (PMID: 11440741)
Eur J Neurosci. 2006 May;23(10):2648-56. (PMID: 16817867)
Curr Alzheimer Res. 2005 Oct;2(4):419-23. (PMID: 16248847)
Biomark Insights. 2007 May 03;2:128-46. (PMID: 19662198)
J Neuroinflammation. 2011 Oct 20;8:144. (PMID: 22014002)
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18126-31. (PMID: 22010221)
PLoS Biol. 2008 Jul 22;6(7):e182. (PMID: 18651793)
J Neuroinflammation. 2016 Aug 30;13(1):212. (PMID: 27578023)
Neurotox Res. 2007 Dec;12(4):269-74. (PMID: 18201954)
- Grant Information:
No.5/4-5/128/Neuro/CAR/2013-NCD-I Indian Council of Medical Research; BT/PR/4054/Med/30/349/2010 Department of Biotechnology, Govt. of India
- Contributed Indexing:
Keywords: Amyotrophic lateral sclerosis; Biomarker; Chitotriosidase; Glia; Neurodegeneration; Neuroinflammation
- الرقم المعرف:
0 (Biomarkers)
EC 3.2.1.- (Hexosaminidases)
EC 3.2.1.- (chitotriosidase)
- الموضوع:
Date Created: 20200809 Date Completed: 20210702 Latest Revision: 20240731
- الموضوع:
20250114
- الرقم المعرف:
PMC7412641
- الرقم المعرف:
10.1186/s12974-020-01909-y
- الرقم المعرف:
32762702
No Comments.